Early warning of sepsis using a new blood test
Part of Infections clinical trials.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your MSS score (a measure of possible infection severity) must be 2 or higher.
- If admitted to the ICU, you must stay for at least 24 hours.
- You cannot have cancer, HIV, or any terminal illness.
- You cannot be pregnant or breastfeeding.
- You must agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This trial tests a new blood test called the Sepsis ImmunoScore that may help doctors quickly identify sepsis (a life-threatening infection response). The test looks at your immune system's response to see if you have sepsis, which could help you get treatment faster.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This trial tests a new way to detect sepsis using fluorescence from a blood sample. It may help doctors identify sepsis earlier and improve treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.